Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Progenics Pharmaceuticals, Inc."
Count: 31
Selected: 0
NCT IDTitle
NCT03939689Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone
NCT02981368Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
NCT03739684Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
NCT02020135An Open-label Extension Study of PSMA ADC 2301 in mCRPC
NCT01695044A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT01414296Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
NCT01414283Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
NCT00055185Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients
NCT00605644Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain
NCT00547586Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain
NCT00936884Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation
NCT00858754Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects
NCT00529087Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain
NCT01186770A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain
NCT00528970A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair
NCT00672477Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness
NCT00672139Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness
NCT04030338Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer
NCT03495427PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
NCT04461509High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
NCT04457245Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
NCT03525288PSMA-PET Guided Radiotherapy
NCT0472773618F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer
NCT03471650Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer
NCT02825875Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer
NCT03392181PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
NCT04266392Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand
NCT03030885Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT04984343Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer
NCT01856933BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
NCT04614766A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors